← FDA DRUG APPROVALS
FDA ANDA · ANDA077355
ACID REDUCER PLUS ANTACID
famotidine, calcium carbonate and magnesium hydroxide
Sponsor: PERRIGO R AND D
APPLICATION
ANDA077355
TYPE
ANDA
ORIGINAL APPROVAL
2008-02-06
LATEST ACTION
2008-02-06
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Over-the-counter
Products
FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDEOver-the-counter
CALCIUM CARBONATE 800MG, FAMOTIDINE 10MG, MAGNESIUM HYDROXIDE 165MG · TABLET, CHEWABLE · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.